Archive for the ‘Lyme’ Category

Dancing With Lyme Disease: A Story of Ebb, Flow & Coming Back to Life

https://www.elephantjournal.com/2020/07/dancing-with-lyme-disease-a-story-of-ebb-flow-and-coming-back-to-life/

Dancing with Lyme Disease: A story of Ebb, Flow & Coming Back to Life.

When I was first diagnosed with late-stage (chronic) Lyme disease, my doctor told me that the recovery process would be like a dance.

“Sometimes, the infection will take the lead and be in control of your body,” he said, “Other times, the strength of your health will take control.”

Twelve months into treatment, this phrase has held me steady.

Through my temporary remissions and temporary relapses, I have observed the line of equilibrium between the illness in my body and the health of my body bending to and fro. I have been lifted by my health during periods of remission, and I have fallen to my knees at the hands of the disease in times of relapse. The highs and lows of living with this disease are inexplicable to describe to the layperson.

There is both a rhythm and a pattern to Lyme disease.

(See link for article)

_____________________

**Comment**

Key Quote:  

There is currently no agreed-upon or approved treatment guideline for Late-stage Lyme disease. It is relentlessly undiagnosed, misdiagnosed, and improperly treated, globally. It is an epidemic that no one is talking about, and it does not receive the medical recognition, research, funding, and support that it warrants.

Firstgreat read.  Many of you will identify with this story on many levels – but please remember that there is a lot of overlap with coinfections and the symptoms they cause.  Don’t read this and think it’s a “10 Commandments” type of thing where if she says she had certain symptoms and blamed a certain pathogen, that that is what you will have.  This looks so differently on everyone.  There are certain hallmark symptoms but it varies wildly from person to person.

Second – it took me years to find a pattern.  Seriously – I questioned my own sanity often!  And I wanted to change doctors often!  One of the hardest things to accept is that if you are chronically/persistently infected, treatment is going to suck big time and it’s going to typically take YEARS, not months or weeks of treatment.  Then, there will probably be relapses that will bring you down, down to goblin town.  It will be depressing for sure, but stay the course!  I can encourage you that with each stint of treatment we used for relapses we got better and better.

Third – while this complex illness, which I choose to call Lyme/MSIDS (multi systemic infectious disease syndrome), does not receive the research and funding it needs, we must refrain from just blindly obtaining money as we have in the past.  Research has been pigeon-holed into an accepted narrative by ‘authorities’ who have severe conflicts of interest and are extremely biased.

Since the Health and Human Services (HHS) can not lobby for money, they get Lyme patients and advocates to do it for them.  Then they turn around and hand the money over to the same people who have these conflicts of interest.  They focus on the acute phase of the disease and completely deny persistent infection – choosing rather to believe in a “post-treatment Lyme disease syndrome.”  Since their definition of this term does NOT include a persistent infection(s) they will not advocate for extended antimicrobials.  In fact they’ve made it clear they feel extended treatment is harmful.

I compare this asinine stance to a strep throat infection where if the patient still had symptoms after treatment, calling it post-treatment strep syndrome and sending the patient home with an anti-depressant because they are obviously making it all up.  This is precisely what they do to Lyme/MSIDS patients who continue with symptoms after the CDC’s 21 day mono-therapy of doxycycline, which BTW will not touch many coinfections at all.

So Lyme advocates and patients must be “innocent as doves but wise as snakes” when it comes to obtaining money for government sponsored research.  I feel strongly we need to raise our own monies and utilize independent researchers who are truly going to be transparent and unbiased in their work.  The study design should also be evaluated and approved by others who are experts – preferably patients themselves before its completed so that we actually get work done on important issues – done in a manner that takes into account the extended nature of the disease(s).  So many studies are done without lengthy enough follow-up.

I wrote about all of this recently here: https://madisonarealymesupportgroup.com/2020/08/02/house-approves-increased-funding-for-lyme-im-not-impressed-please-contact-congressman-pallone/

Again, while well-intentioned, it will be handing money to the exact same players it’s gone to in the past who are not to be trusted.  Within the link I include Congressman Pallone’s contact information.  Contact him and tell him you demand a hearing with HHS over these important points before they get another dime of tax payer money.

 

Slyme – An Interview & We Need to Drop the Term PTLD Like a Bad Habit!

https://podcast.tickbootcamp.com/episode/bef83ae435ca43b4/slyme-an-interview-with-jenna-luch-thayer

S1E102 – Slyme – an interview with Jenna Luché-Thayer

Ms. Luché-Thayer is the 59-year-old founder and director of the Ad Hoc Committee for Health Equity in ICD11 Borreliosis Codes

Tick Boot Camp’s guest today is Jenna Luché-Thayer. Ms. Luché-Thayer is the 59-year-old founder and director of the Ad Hoc Committee for Health Equity in ICD11 Borreliosis Codes, and she’s from Florida. She first experienced the symptoms of a tick disease in 1976, when she was just 16 years old. She had a fever, extreme fatigue, joint pain, and Bell’s palsy. Her illness came and went, but it took over 35 years for Ms. Luché-Thayer to receive a Lyme diagnosis. This expert brilliantly details what it is like to be a woman on the Lyme journey. If you would like to learn more about the amazing work that Ms. Luché-Thayer has done to give back to the Lyme community since her diagnosis, then tune in now!

Thayer also recently wrote a very timely article on how we need to drop the term “post treatment Lyme disease” like a bad habit:
https://www.linkedin.com/pulse/reasons-lyme-nonprofits-disown-post-treatment-disease-luche-thayer/

Reasons for Lyme Nonprofits to Disown Post Treatment Lyme Disease Syndrome: A Case Study

Jenna Luche-Thayer

Senior Advisor – US Government, United Nations, non-profits, corporate social responsibility programs

INTRODUCTION

The denial of evidence showing persistent Lyme infection is a critical obstacle to adequate treatment. This case study demonstrates how funding Post Treatment Lyme Disease Syndrome (PTLDS) and Post Treatment Lyme Symptoms (PTLS) research may create further impediments to sufficient treatment. PTLDS/PTLS are terminology developed for ‘limited research constructs’. These research terms are frequently misappropriated as clinical diagnoses that wrongly infer underlying infection has been adequately treated —even when the patient has recurring symptoms [1].

Persons suffering from persistent Lyme infection, or any chronic illness, may develop secondary psychosomatic and psychiatric disorders. The misuse of PTLDS/PTLS in clinical settings often results in treatment limited to the secondary psychosomatic and psychiatric disorders and denial of adequate antimicrobials for the underlying infection.

This situation is encouraged by government funders of PTLDS/PTLS studies that tend to concentrate on possible psychosomatic and psychiatric aspects of PTLDS/PTLS and largely ignore infectious causes.

This case study is limited to the PTLDS/PTLS research focus by one influential Lyme patient advocacy organization, namely the Lyme Disease Association, Inc (LDA). This organization was chosen because they have the only patient advocate who is a voting member of the Federal Tick Borne Diseases Working Group. This assessment is based on information taken from the LDA website —53 Publications for LDA-Funded Research— and focuses on the 11 publications that use PTLDS/PTLS terminology. (See tables below for publication details —retrieved July 20, 2020)

(See link for article)

For more:  https://madisonarealymesupportgroup.com/2020/01/15/jenna-luche-thayer-australian-lyme-a-global-view/

Chicago Saxophonist Shares Cassidy Marks Comeback From Tough Illness

https://www.chicagotribune.com/entertainment/music/howard-reich/ct-ent-sharel-cassity-reich-

By Howard Reich

Aug. 4, 2020

If you listen to Chicago saxophonist Sharel Cassity’s compelling new album, the aptly named “Fearless,” you never would know how ill she was when she recorded it.

Her tone sounds full, her technique nimble, the joy of her music-making unmistakable.

But just a few weeks before the recording sessions in July 2019, Cassidy received a diagnosis for why she had felt sick for the past year:  post-Lyme disease.  (See link for article)

____________________

**Comment**

Please know there is disagreement in the medical community over what causes lingering symptoms with Lyme/MSIDS.  The author threw the accepted mainstream label “post-Lyme disease” on it but this assumes the infection is gone when there is much to show it isn’t.

  1. First, there’s hundreds of studies showing it: Peer-Reviewed Evidence of Persistence of Lyme:MSIDS copy
  2. Second, the ‘authorities’ in charge of the narrative as well as decisions have severe conflicts of interest and can not be trusted:  https://madisonarealymesupportgroup.com/2020/04/26/cdc-playbook-learning-from-lyme/ and https://madisonarealymesupportgroup.com/2019/02/22/why-mainstream-lyme-msids-research-remains-in-the-dark-ages/.
  3. Third, experience.  I’ve lived it.  My husband lived it.  Thousands of others have lived it.  And extended anti-microbials continue to work on us – as is clearly seen by continuing herxheimer reactions.  If a normal, uninfected person were to take antibiotics they would feel nothing.  When a person infected with Lyme/MSIDS takes antibiotics they typically suffer with herxheimer reactions.  Please see:  https://madisonarealymesupportgroup.com/2015/08/15/herxheimer-die-off-reaction-explained/ and https://madisonarealymesupportgroup.com/2017/06/28/jarisch-herxheimer-a-review/.

This article is misleading and while Cassidy truthfully states,

“If you have it over a year, apparently it doesn’t really ever go away,”

She also misleadingly calls it post-Lyme disease.  

If you had strep throat and took medication for it but still had symptoms after the medication was stopped would you call it “post strep infection?”  Yet this is what our ‘authorities’ who have vested interests in vaccine creation and patents do.  They know that you can’t have a vaccine for a chronic illness – therefore, they will not allow Lyme/MSIDS to be a continuing infection that would benefit from extended treatment because it interferes with their lucrative patents.

You may think this is unwarranted skepticism.  Let me ask you a question: if you stood behind a horse and it kicked you how many more times would you get behind that horse?  The Lyme community continues to get behind horses that kick them!

An IDSA founder, Dr. Waisbren (who happened to practice medicine in Wisconsin) disagreed with his colleagues upon the way Lyme/MSIDS was handled and wrote a fascinating book where he used grams of IV antibiotics in many of his patients successfully:  https://madisonarealymesupportgroup.com/2017/07/09/idsa-founder-used-potent-iv-antibiotics-for-chronic-lyme/

Similarly to the smear campaign by ‘authorities’ on hydrochloroquine for COVID, there’s been a full-court press against IV antibiotics for Lyme:  https://madisonarealymesupportgroup.com/2017/06/23/no-bias-in-mmwr-for-any-other-infectious-disease-requiring-iv-antibiotics-except-for-lyme/

Dr. Maloney has written about the bias within the CDC on Lyme/MSIDS:  https://madisonarealymesupportgroup.com/2020/03/11/cdcs-recommendations-for-lyme-epitomize-institutional-bias/

What’s truly saddening is that Cassidy is considering other careers “when her fingers eventually no longer worked.”  If you are told and believe that this is “post-Lyme disease,” you are not going to consider continuing treatment for an infection.  You will only consider adjunctive therapies that are essentially band-aids that don’t get to the root of the problem – an ongoing infection.  Therefore, it’s highly likely your fingers, along with everything else, will worsen.

Personal note:  We have benefited from antibiotic treatment every single time we have relapsed.  In fact those stints of treatment got us better than we’d ever been before on treatment.

What do you do with this information?  Do you seriously believe this is something we could make up?  How about the thousands of others who experienced the same thing – are they imagining this improvement as well – which BTW is sustainable, not a fleeting thing?

 

 

FREE Webinars on Ticks, Lyme, & Prevention

https://extension.psu.edu/catalogsearch/result/?education_format=810&q=tick

EDUCATION

Tick Series: Hunters and Vector-Borne Disease - A Tick-ing Time Bomb

Tick Series: Hunters and Vector-Borne Disease - A Tick-ing Time Bomb - Webinars WEBINARS

Free
Attend this Live webinar to learn how to protect yourself from ticks and other vector-borne diseases this hunting season!
Tick Series: Protecting Your Horses from Tick Bites

Tick Series: Protecting Your Horses from Tick Bites - Webinars WEBINARS

Free
Learn how to treat horses and their environments to prevent ticks with this live webinar!
Tick Series: Tick Risks for Pennsylvania Cattle

Tick Series: Tick Risks for Pennsylvania Cattle - Webinars WEBINARS

Free
Learn how to control ticks in your herd with this webinar.
Tick Series: Lyme Disease and Other Tick-Borne Diseases

Tick Series: Lyme Disease and Other Tick-Borne Diseases - Webinars WEBINARS

Free
Tick prevention, treatment, and more will be covered in this Live webinar.
Tick Series: Protecting Yourself from Tick Bites

Tick Series: Protecting Yourself from Tick Bites - Webinars WEBINARS

Free
Learn how to prevent tick bites during this live webinar!
Deer tick, National Park Service.

Time to Talk Ticks: Symptoms, Treatment, and Prevention - Webinars WEBINARS

Free
Two experts weigh in on a variety of tick-related topics, from tick habitats to common tick diseases, and how they affect horses.
Extension at Home: Preventing Tick and Mosquito Bites

Extension at Home: Preventing Tick and Mosquito Bites - Webinars WEBINARS

Free
Join us for the Extension at Home webinar series to prepare and protect your outdoor sanctuary.
Tick Series: Vector-Borne Disease Basics

Tick Series: Vector-Borne Disease Basics - Webinars WEBINARS

Free
Learn about the basics of vector-borne diseases in Pennsylvania during this live webinar.
Tick Series: Identification, Distribution, and Natural History

Tick Series: Identification, Distribution, and Natural History - Webinars WEBINARS

Tick Series: Identification, Distribution, and Natural History

Learn about the many species of ticks found in Pennsylvania during this live webinar.

Tick Series: Tick Protection Around the Home

Tick Series: Tick Protection Around the Home - Webinars WEBINARS

Tick Series: Tick Protection Around the Home

Join our informative webinar to learn how to protect you and your family from tick bites while still enjoying your backyard this season!
Tick Series: Ecology and How to Approach Tick Control

Tick Series: Ecology and How to Approach Tick Control - Webinars WEBINARS

Free
This live webinar will discuss tick development, hosts, and where ticks are found.
Tick Series: Protecting Pets from Tick-Borne Disease

Tick Series: Protecting Pets from Tick-Borne Disease - Webinars WEBINARS

Tick Series: Protecting Pets from Tick-Borne Disease

Ticks carry diseases that can greatly affect the health of your pets. Learn how to protect your pets from tick-borne diseases during this informative webinar.

Ticks Climb the Mountains: Ixodes Tick Infestation and Infection by Tick-Borne Pathogens

https://pubmed.ncbi.nlm.nih.gov/32723635/

. 2020 Sep;11(5):101489.

doi: 10.1016/j.ttbdis.2020.101489.Epub 2020 Jun 8.

Ticks climb the mountains: Ixodid tick infestation and infection by tick-borne pathogens in the Western Alps

Abstract

In mountain areas of northwestern Italy, ticks were rarely collected in the past. In recent years, a marked increase in tick abundance has been observed in several Alpine valleys, together with more frequent reports of Lyme borreliosis. We then carried out a four-year study to assess the distribution and abundance of ticks and transmitted pathogens and determine their altitudinal limit in a natural park area in Piedmont region.

  • Ixodes ricinus (castor bean tick) and Dermacentor marginatus (ornate sheep tick) were collected from both the vegetation and hunted wild ungulates.
  • Tick abundance was significantly associated with altitude, habitat type and signs of animal presence, roe deer’s in particular.
  • Ixodes ricinus prevailed in distribution and abundance and, although their numbers decreased with increasing altitude, we recorded the presence of all active life stages of up to around 1700 m a.s.l., with conifers as the second most infested habitat after deciduous woods.
  • Molecular analyses demonstrated the infection of questing I. ricinus nymphs with B. burgdorferi sensu lato (15.5 %), Rickettsia helvetica and R. monacensis (20.7%), Anaplasma phagocytophilum (1.9 %), Borrelia miyamotoi (0.5 %) and Neoehrlichia mikurensis (0.5 %).
  • One third of the questing D. marginatus were infected with R. slovaca.
  • We observed a spatial aggregation of study sites infested by B. burgdorferi s.l. infected ticks below 1400 m. Borrelia-infected nymphs prevailed in open areas, while SFG rickettsiae prevalence was higher in coniferous and deciduous woods.
  • Interestingly, prevalence of SFG rickettsiae in ticks doubled above 1400 m, and R. helvetica was the only pathogen detected above 1800 m a.s.l.
  • Tick infestation on hunted wild ungulates indicated the persistence of tick activity during winter months and, when compared to past studies, confirmed the recent spread of I. ricinus in the area.

Our study provides new insights into the population dynamics of ticks in the Alps and confirms a further expansion of ticks to higher altitudes in Europe. We underline the importance of adopting a multidisciplinary approach in order to develop effective strategies for the surveillance of tick-borne diseases, and inform the public about the hazard posed by ticks, especially in recently invaded areas.

______________________

**Comment**

Not that ticks can’t climb mountains – but migrating birds probably dropped them there:  https://madisonarealymesupportgroup.com/2018/11/07/ticks-on-the-move-due-to-migrating-birds-and-photoperiod-not-climate-change/

https://madisonarealymesupportgroup.com/2019/03/09/danish-study-shows-migrating-birds-are-spreading-ticks-their-pathogens-including-places-without-sustainable-tick-populations/

Regarding R. slovaca:

We also identified a case of R. slovaca infection in southern Rhineland-Palatinate. The patient reported a tick bite; the tick was identified as Dermacentor spp. Fever, lymphadenopathy of submandibular lymph nodes, and exanthema at the site of the tick bite developed 7 days later. Serologic examinations by using an immunofluorescent test (Focus Diagnostics, Cypress, CA, USA) showed antibody titers of 64 for immunoglobulin (Ig) M and 1,024 for IgG against rickettsiae of the spotted fever group. These results indicated an acute rickettsial infection. Because of strong cross-reactivity among all species in the spotted fever group, we cannot differentiate between antibodies against R. slovaca and other species in this group.  https://wwwnc.cdc.gov/eid/article/15/12/09-0843_article